Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., and MedinCell announced that the U.S. Food and Drug Administration has approved UZEDY extended-release injectable suspension for the treatment of schizophrenia in adults.
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., and MedinCell announced that the U.S. Food and Drug Administration has approved UZEDY extended-release injectable suspension for the treatment of schizophrenia in adults.